Johnson & Johnson’s pharmaceutical arm, Janssen, embarked on a global effort to combat the COVID-19 pandemic. To support their goal of supplying one billion doses of vaccine, an agreement with a contract manufacturer was reached. Large-scale manufacturing of Janssen’s vaccine would take place at the contract manufacturing site, which is designed for rapid manufacturing of vaccines and other treatments in large quantities during public health emergencies.
ACC’s Smart Solution for a secure data pipeline to support Covid vaccine manufacturing
![](https://biobuzz.io/wp-content/uploads/2021/08/ACC-300x168.jpg)